Last reviewed · How we verify
NCT05881499
The Effects of Earthquake on Fear of Movement and Fear of Falling
trial in Fear of Movement in 185 participants. Completed in 1 September 2023.
1 August 2023
Quick facts
| Lead sponsor | Nagihan Acet |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 185 |
| Start date | 28 June 2023 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Fear of Movement — all drugs for Fear of Movement →
- Fear of Falling — all drugs for Fear of Falling →
Sponsor
Nagihan Acet
Who can join
Adults 18 to 60, any sex, with Fear of Movement or Fear of Falling. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In February-March 2023, a series of major earthquakes occurred in 11 provinces of Turkey (Adana, Adıyaman, Diyarbakır, Gaziantep, Hatay, Kahramanmaraş, Kilis, Malatya, Osmaniye, Şanlıurfa and Elazığ). The current study is planned as a observational cross-sectional study with the participation of the survivors who experienced the 2023 earthquakes and aftershocks in Turkey without any physical injury during or after the earthquake. It is planned for the participants to fill out the questionnaires by considering the time periods before and after the earthquake. While the primary outcome is fear of movement and fear of falling, the secondary outcome is level of physical activity and intensity of pain. Psychological resilience level was considered as a predictive factor. The aim of the current study is to determine the effect of earthquake experience on the fear of movement and falling in earthquake victims and to investigate the factors related with them. Fear of movement, fear of falling, level of physical activity, intensity of pain and psychological resilience are evaluated with the Causes of Fear of Movement Scale, Modified Falls Efficacy Scale, Short Form of International Physical Activity Questionnaire, Numerical Pain Scale and Connor-Davidson Psychological Resilience Scale respectively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05881499
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nagihan Acet trials
Trials by the same sponsor.
- NCT06689319 — Factors Linked to AI Literacy in University Students · completed
- NCT06634238 — Acute Mask Effects on Walk Distance and Vital Signs · not yet recruiting
- NCT06603493 — Headaches: Effects on Sleep, Sensitization, and Psychological Factors · completed
- NCT06598774 — Cervical Parameters and Body Awareness in Relation to Smartphone Addiction · completed
- NCT06559397 — Proprioceptive Puzzle: Effects on Quantitative Sensory Tests and Body Awareness · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05881499 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagihan Acet
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05881499.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing